13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Thoracic fluid accumulation and asthma symptoms: A new contributor mechanism

      meeting-report
      , PT, PhD a , , BME, PhD a , b ,
      Porto Biomedical Journal

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Asthma is a chronic disease that affects about 300 million people worldwide. 1 Asthma is a heterogeneous disease, defined by variable expiratory airflow limitation and history of respiratory symptoms such as wheeze, shortness of breath, chest tightness, and cough. 2 The cardinal feature of asthma is excessive narrowing of the lower airways. Excessive airway narrowing accounts for the morbidity and mortality of asthma and it makes breathing difficult or, in the extreme, impossible. 3 4 5 Despite the advances in pharmacological treatment options, a large fraction of asthma sufferers has poor asthma control. 6 For example, in Canada, it is estimated that asthma is not well-controlled in 90% of asthmatics. 7 The presence of nocturnal symptoms is an important marker of poor asthma control. 8 Indeed, 50% to 68% of asthma attacks that led to death occur during night. 9 10 11 12 However, the mechanisms accounting for nocturnal worsening of asthma remain unclear. 3 It is well known that sleep changes respiratory mechanics, including reductions in respiratory drive, pharyngeal dilator muscle tone, and lung volume. 13 14 15 However, the changes in respiratory mechanics during sleep do not account for all the nocturnal increases in airflow resistance in asthma. For example, maintaining lung volumes similar to the wakefulness values by continuous negative pressure applied to the chest during sleep does not prevent the overnight increase in airway resistance. 16 17 Moreover, whether awake or asleep, airway resistance increases overnight and doubles with sleep. 18 This shows independent contribution of sleep over circadian effects. Recent evidences show that rostral fluid shift from the legs to the thorax during supine posture 19 20 and fluid overloading 21 are potential contributors to poor asthma control and nocturnal worsening of asthma symptoms. Fluid accumulation in the thorax may cause a cascade of events that exacerbate airway narrowing. 19 These events include increased blood volume and blood pressure in the bronchial circulation. 22 23 As a result, the pressure gradient from blood to interstitium increases, drives more fluid leak, and causes increased airway wall edema, 24 25 26 and peribronchial fluid cuffing. 24 25 27 These events can lead to the excessive airway narrowing 25 26 27 and airway hyper-responsiveness 26 that contribute to asthma severity and fatality. 28 29 30 31 Our group has been investigating the effects of rostral fluid shift on lower airway narrowing in asthma. 19 20 In order to control for the confounding effects of sleep on airway resistance, we performed a daytime study in healthy controls and patients with asthma. 19 20 We simulated nocturnal rostral fluid shift by applying lower body positive pressure with inflatable trousers. After 30 minutes, lower body positive pressure moved similar amount of fluid out of the legs to that which happens overnight. We found that despite similar amount of fluid moving to the thorax in healthy controls and asthmatics with lower body positive pressure: (1) only in asthmatics, fluid accumulation in the thorax increased lower airway narrowing 19 ; (2) changes in lower airway resistance were directly related to the amount of fluid moving to the thorax 19 ; and (3) the effects of fluid shift were larger in women than in men. 20 Airway resistance is inversely related to the forth power of airway diameter. For similar amount of fluid accumulating in the airway wall, airway wall becomes thicker in smaller airways than larger airways. Thus, airway lumen narrows more and its resistance increases more in patients with narrower airways at baseline. Women have narrower airways than men even at similar lung volumes 32 and women are at higher risk of nocturnal asthma than men. 33 34 Thus, rostral fluid shift may have larger effects in airway narrowing in asthmatics with smaller airways, such as women, obese patients, and those with more severe asthma. Kantor et al 21 investigated the relationship between fluid overload and asthma exacerbation. In children admitted for asthma exacerbation, they performed a large retrospective cohort study over 7 years to evaluate fluid balance and clinical outcomes. In particular, they investigated length of in-hospital stay and duration of administration of beta agonist and supplemental oxygen. 21 They calculated the percentage of fluid overload as the difference between fluid intake and fluid output normalized by the admission weight in the first 72 hours of hospitalization. They found that peak fluid overload ≥7% was associated with worse clinical outcomes, such as longer length of hospital stay, longer treatment duration, and increased risk of supplemental oxygen use. 21 Kantor et al validated their results in a sample of subjects with multiple hospitalizations, finding similar results in matched sample. 21 The same study 21 investigated the physiological mechanisms that may contribute to worse clinical outcomes in patients with asthma and fluid overload. In a prospective observational cohort, they showed that patients with peak fluid overload ≥7% had more negative swings in inspiratory intrapleural pressure and evidence of extravascular lung water, as assessed, respectively, by the variation in peak aortic velocity and the cumulative number of B-lines in ultrasound images of lung. 21 Their findings were in agreement with their hypothesis that during asthma exacerbation, the excessive airway narrowing increases the negative pleural pressure which pulls part of the extra fluid to the lungs and increases extravascular lung water. The findings from Bhatawadekar et al 19 20 and Kantor et al 21 have important clinical implications, especially for the patients with difficult-to-treat asthma. So far, the recognized risk factors for asthma exacerbation include severe nasal sinus disease, gastroesophageal reflux, recurrent respiratory infection control, physiological dysfunctioning (such as depression and anxiety), and obstructive sleep apnea (OSA). 35 Among the recognized risk factors for asthma exacerbation, OSA is one with unclear pathophysiological mechanism. Asthma and OSA coexist in up to 30% of patients with either disorder. 9 36 37 38 Moreover, in patients with difficult-to-control asthma, prevalence of OSA is about 90%. 39 Interestingly, previous studies have shown that overnight rostral fluid shift is associated with worsening of OSA by increasing fluid accumulation in the neck that narrows the pharynx, increasing its resistance and collapsibility. 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 During OSA, the pharynx collapses; causing strong inspiratory efforts against the occluded pharynx to resume inspiration. The result is large negative (subatmospheric) intrapleural pressures that increase venous return. The OSA events associated with the overnight rostral fluid shift may increase even more the accumulation of fluid in the chest, aggravating the airway narrowing and hyper-responsiveness. Indeed, OSA is associated with up to 7 times greater risk of having severe asthma 38 58 and 3.4 times increased risk of asthma exacerbations. 35 However, the overlap between asthma and OSA is poorly recognized. Thus, both patients and physicians may not attribute sleep problems and poor asthma control to the OSA. Recognizing fluid accumulation in the thorax as a risk factor for poor asthma control, difficult-to-treat asthma, and worse clinical outcomes in asthma has the potential to reveal new treatments to improve asthma control and change the clinical management of asthma. Asthma patients may benefit from simple treatments to reduce fluid retention in the legs such as wearing compression stockings or physical exercise. In fact a recent systematic review from our group showed that physical exercise improves nocturnal asthma in children and adults by reducing the prevalence and frequency of nocturnal symptoms. 59 In our review, we could not determine the mechanisms by which physical exercise could improve nocturnal asthma. However, the reduction of rostral fluid shift by reducing fluid retention in the legs may be one of the mechanisms related with the improvements in nocturnal asthma. While rostral fluid shift occurs in everyone during sleep, it is likely to exert detrimental effects on airway narrowing in other high-risk populations including: (i) pregnant women, postoperative patients, and patients with heart or renal failure; (ii) individuals with limited mobility or sedentary lifestyle; and (iii) the elderly who have stiffer arteries and/or compromised cardiac function. Finally and importantly, in patients with asthma exacerbation, controlling the fluid balance to avoid fluid overload can potentially improve the clinical outcomes, reducing the risks and costs associated with long-term hospitalization. In conclusion, in asthma, fluid overload and fluid accumulation in the thorax can be potential contributing factors for worsening of asthma symptoms and poor clinical outcomes. More studies are needed to understand the mechanism of asthma worsening due to fluid accumulation in the thorax and to identify the specific asthma phenotypes in adults and children who are at higher risk of asthma worsening due to the fluid accumulation in the thorax. A better understanding of these mechanisms has the potential to facilitate development of new treatments and prevent the pernicious effects of asthma exacerbations. Acknowledgments Supported by Canadian Respiratory Research Network, Allergen NCE and Ontario Lung Association. Conflicts of interest The authors declare no conflicts of interest.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          Pathophysiology of sleep apnea.

          Sleep-induced apnea and disordered breathing refers to intermittent, cyclical cessations or reductions of airflow, with or without obstructions of the upper airway (OSA). In the presence of an anatomically compromised, collapsible airway, the sleep-induced loss of compensatory tonic input to the upper airway dilator muscle motor neurons leads to collapse of the pharyngeal airway. In turn, the ability of the sleeping subject to compensate for this airway obstruction will determine the degree of cycling of these events. Several of the classic neurotransmitters and a growing list of neuromodulators have now been identified that contribute to neurochemical regulation of pharyngeal motor neuron activity and airway patency. Limited progress has been made in developing pharmacotherapies with acceptable specificity for the treatment of sleep-induced airway obstruction. We review three types of major long-term sequelae to severe OSA that have been assessed in humans through use of continuous positive airway pressure (CPAP) treatment and in animal models via long-term intermittent hypoxemia (IH): 1) cardiovascular. The evidence is strongest to support daytime systemic hypertension as a consequence of severe OSA, with less conclusive effects on pulmonary hypertension, stroke, coronary artery disease, and cardiac arrhythmias. The underlying mechanisms mediating hypertension include enhanced chemoreceptor sensitivity causing excessive daytime sympathetic vasoconstrictor activity, combined with overproduction of superoxide ion and inflammatory effects on resistance vessels. 2) Insulin sensitivity and homeostasis of glucose regulation are negatively impacted by both intermittent hypoxemia and sleep disruption, but whether these influences of OSA are sufficient, independent of obesity, to contribute significantly to the "metabolic syndrome" remains unsettled. 3) Neurocognitive effects include daytime sleepiness and impaired memory and concentration. These effects reflect hypoxic-induced "neural injury." We discuss future research into understanding the pathophysiology of sleep apnea as a basis for uncovering newer forms of treatment of both the ventilatory disorder and its multiple sequelae.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global strategy for asthma management and prevention: GINA executive summary.

            Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effectively. However, recommendations for asthma care need to be adapted to local conditions, resources and services. Since it was formed in 1993, the Global Initiative for Asthma, a network of individuals, organisations and public health officials, has played a leading role in disseminating information about the care of patients with asthma based on a process of continuous review of published scientific investigations. A comprehensive workshop report entitled "A Global Strategy for Asthma Management and Prevention", first published in 1995, has been widely adopted, translated and reproduced, and forms the basis for many national guidelines. The 2006 report contains important new themes. First, it asserts that "it is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained," and recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions. The importance of the patient-care giver partnership and guided self-management, along with setting goals for treatment, are also emphasised.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Remodeling in asthma and chronic obstructive lung disease.

              Asthma and chronic obstructive lung disease (COPD) are both inflammatory conditions of the lung associated with structural "remodeling" inappropriate to the maintenance of normal lung function. The clinically observed distinctions between asthma and COPD are reflected by differences in the remodeling process, the patterns of inflammatory cells and cytokines, and also the predominant anatomic site at which these alterations occur. In asthma the epithelium appears to be more fragile than that of COPD, the epithelial reticular basement membrane (RBM) is significantly thicker, there is marked enlargement of the mass of bronchial smooth muscle, and emphysema does not occur in the asthmatic nonsmoker. In COPD, there is epithelial mucous metaplasia, airway wall fibrosis, and inflammation associated with loss of surrounding alveolar attachments to the outer wall of small airways: bronchiolar smooth muscle is increased also. Emphysema is a feature of severe COPD: in spite of the destructive process, alveolar wall thickening and focal fibrosis may be detected. The hypertrophy of submucosal mucus-secreting glands is similar in extent in asthma and COPD. The number of bronchial vessels and the area of the wall occupied by them increase in severe corticosteroid-dependent asthma: it is likely that these increases also occur in severe COPD as they do in bronchiectasis. Pulmonary vasculature is remodeled in COPD. In asthma several of these structural alterations begin early in the disease process, even in the child. In COPD the changes begin later in life and the associated inflammatory response differs from that in asthma. The following synopsis defines and compares the key remodeling processes and proposes several hypotheses.
                Bookmark

                Author and article information

                Journal
                Porto Biomed J
                PJ9
                Porto Biomedical Journal
                2444-8664
                2444-8672
                Nov-Dec 2019
                10 July 2019
                : 4
                : 6
                : e40
                Affiliations
                [a ]KITE, Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada
                [b ]Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
                Author notes
                []Corresponding author. KITE, Toronto Rehabilitation Institute, University Health Network, 550 University Ave, Room 12-106, Toronto, ON, M5G 2A2. E-mail address: Azadeh.Yadollahi@ 123456uhn.ca (Azadeh Yadollahi)

                Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

                Article
                PBJ-D-19-00008 00001
                10.1097/j.pbj.0000000000000040
                7819536
                071ded2d-a6c2-46a2-ba4d-ab917979f79b
                Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of PBJ-Associação Porto Biomedical/Porto Biomedical Society. All rights reserved.

                This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

                History
                : 28 February 2019
                : 18 June 2019
                Categories
                Invited Commentary
                Custom metadata
                TRUE

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content7

                Cited by1

                Most referenced authors565